(Q70277482)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6351040%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

title

The patient, disease status, and treatment options for prostate cancer: stages D1 and D2 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6351040%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

The patient, disease status, and treatment options for prostate cancer: Stages D1 and D2 (English)

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

5 October 2023

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

5 October 2023

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

5 October 2023

author name string

J. D. Schmidt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6351040

5 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6351040

5 October 2023

publication date

1 January 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6351040%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

10 October 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.2990040508

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

https://onlinelibrary.wiley.com/doi/full/10.1002/pros.2990040508

5 October 2023

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

5 October 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6351040%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6351040%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6351040%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

493-501

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6351040%20AND%20SRC:MED&resulttype=core&format=json

Response criteria for the prostate of the USA national prostatic cancer project

10 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

The importance of the stable category for chemotherapy treated patients with advanced and relapsing prostate cancer

5 October 2023

2

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

Risk factors for the development of distant metastases in patients undergoing pelvic lymphadenectomy for prostatic cancer

5 October 2023

3

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

Nodal involvement as a prognostic indicator in patients with prostatic carcinoma

5 October 2023

4

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

Radical retropubic prostatectomy and pelvic lymphadenectomy for high-stage cancer of the prostate

5 October 2023

5

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

Chemotherapy Programs of the National Prostatic Cancer Project (NPCP)

5 October 2023

6

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

An experimental approach to the optimum oestrogen dosage in prostatic carcinoma

5 October 2023

9

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate

5 October 2023

10

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

Bilateral orchiectomy for carcinoma of prostate. Response of serum testosterone and clinical response to subsequent estrogen therapy

5 October 2023

11

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

The diagnosis of oestrogen escape and the role of secondary orchiectomy in prostatic cancer

5 October 2023

12

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

Endocrine control of prostatic carcinoma; clinical and statistical survey of 1,818 cases

5 October 2023

13

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

Cancer chemotherapy reports

5 October 2023

15

59

225

Blackard

1975

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

The influence of hormonal therapy on survival of men with advanced prostatic cancer.

5 October 2023

16

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists

5 October 2023

19

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

Comparison of flutamide (SCH-13521) and diethylstilbestrol in untreated advanced prostatic cancer

5 October 2023

20

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

5 October 2023

Cancer Treatment Reports

22

64

813

Glick

1980

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

A phase II study Nolvadex: tamoxifen citrate in the treatment of advanced prostatic adenocarcinoma

5 October 2023

23

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

5 October 2023

Cancer Treatment Reports

24

66

57

Logothetis

1982

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

Cryotherapy of prostate cancer

5 October 2023

25

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040508

5 October 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6351040%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference